Effect of Sar¹-ala⁸-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors

References

• Aurell M., Berglund G., Pettersson M. Renin-angiotensin system in essential hypertension. Lancet 1975; ii: 342
   Google Scholar
• Bartter F. C., Pronove P., Gill J. R., MacCardle R. C. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am. J. Med. 1962; 33: 811
   PubMed Web of Science ®Google Scholar
• Bartter F. C., Gill J. R., Frölich J. C., Bowden R. E., Hollifield J. W., Radfar N., Reiser H. R., Oates J. A., Seyberth H., Taylor A. A. Prostaglandins are overproduced by the kidney and mediate hyper renirtemia in Banter's syndrome. Tr. Av.v. Am. Pins. 1976; 89: 77
   PubMedGoogle Scholar
• Bowden R. E., Gill J. R., Radfar N., Taylor A. A., Keiser H. R. Prostaglandin synthetase inhibitors in Banter's syndrome-effect on immunoreactive prostaglandin-E excretion. JAMA 1978; 239: 117
   PubMedGoogle Scholar
• Brackett N. C., Koppel M., Randall K. E., Nixon W. P. Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome). Am. J. Med. 1968; 44: 803
   PubMedGoogle Scholar
• Bravo E., Banter F. C. The syndrome of juxtaglomerular hyperplasia and hyperaldosteronism without hypertension; studies on pathophysiological mechanisms. Clin. Res. 1968; 16: 263
   Google Scholar
• Chaimowitz C., Levi Y., Better O. S., Oslander L., Benderli A. Studies on the site of renal salt loss in a patient with Banter's syndrome. Peel. Res. 1973; 7: 89
   Google Scholar
• Dusterdieck G., McElwee G. Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Eur. J. clin. Invest. 1971; 2: 32
   PubMed Web of Science ®Google Scholar
• Fichman M. P., Telfer P., Zia N., Speckart P., Golub M., Rude M. Role of prostaglandins in the pathogenesis of Banter's syndrome. Am. J- Med. 1976; 60: 785
   PubMedGoogle Scholar
• Galvez O. G., Bay W. H., Roberts B. W., Ferris T. F. The hemodynamic effect of potassium deficiency in the dog. Circ. Res. 1977; 40: 1–11, Suppl, 1
   PubMedGoogle Scholar
• Giese J., Jörgensen M., Nielsen M. D., Lund J. O., Munck O. Plasma renin measured by use of radioimmunoassay for angiotensin I. Scand J. clin. Lab. Invest. 1970; 26: 455
   Google Scholar
• Gill J. R., Frölich J. C., Bowdens R. E., Taylor A. A., Keiser H. R., Seyberth H. W., Oates J. A., Banter F. C. Banter's syndrome: A disorder characterized by high urinary prostaglandins and a dependency of hyperreninemia on prostaglandin synthesis. A. J. Med. 1976; 61: 43
   PubMed Web of Science ®Google Scholar
• Gill J. R., Bartter F. C., Taylor A. A., Radfar N. Impaired tubular chloride reabsorption as a proximal cause of Banter's syndrome. Clin. Res. 1977; 25: 562A
   Google Scholar
• Goodmans A. D., Vagnucci A. H., Hartroft P. M. Pathogenesis of Banter's syndrome. N. Engl. J. Med. 1969; 281: 1435
   PubMedGoogle Scholar
• Halushka P. V., Wohltmann H., Printern P. J., Huswitz G., Margolius H. S. Banter's syndrome: Urinary prostaglandin-E like material and kalli-krein. Indometacine effects. Am. Int. Med. 1977; 87: 281
   Google Scholar
• Hollenberg N. K., Williams G. H., Burger B., Ishikawa I., Adams D. F. Blockade and stimulation of renal, adrenal and vascular angiotensin II receptors with 1-sar, 8-ala angiotensin II in normal man. J. clin. Invest. 1976; 57: 39
   PubMed Web of Science ®Google Scholar
• Kappelgaard A. M., Ibsen H., Nielsen M. D., Giese J. Radioimmunoassay for saralasin by means of anti-angiotensin II sera. Clin. Chem. Acta 1978; 83: 25
   PubMedGoogle Scholar
• Khuri R. N., Wiederholt M., Stredos N., Giebisch G. Effects of flow rate and potassium intake on distal tubular potassium transfer. Am. J. Physiol. 1975; 228: 1249
   PubMed Web of Science ®Google Scholar
• Modlinger R. S., Nicolis G. L., Krakoff L. R., Gabrilore J. L. Some observations of the pathogenesis of Banter's syndrome. N. Engl. J. Med. 1973; 289: 1022
   PubMedGoogle Scholar
• Norby L., Flamenbaum W. Prostaglandins and aspirin therapy in Banter's syndrome. Lancet 1976; ii: 604
   Google Scholar
• Pettinger W. A., Keeton K., Tanaka K. The radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive man. Clin. Pharmac. Ther. 1975; 17: 146
   PubMedGoogle Scholar
• Posternak L., Brunner H. R., Gavas H., Brunner D. Angiotensin II blockade in normal man. Interaction of renin and sodium in maintaining blood pressure. Kidney Int. 1977; 11: 197
   PubMed Web of Science ®Google Scholar
• Sasaki H., Okumura M., Ikeda M., Kawasaki T., Fukiyma K. Hypotensive response to angiotensin II analogue in Banter's syndrome. N.Engl. J. Med. 1976; 294: 611
   PubMedGoogle Scholar
• Schwartz W. B., van Ypersele de Strihou C., Kassirer J. Role of anions in metabolic alkalosis and potassium deficiency. N. Engl. J. Med. 1968; 279: 630
   PubMed Web of Science ®Google Scholar
• Silverberg A. B., Mennes P. A., Cryer P. E. Resistence to endogenous norepinephrine in Banter's syndrome. Am. J. Med. 1978; 64: 231
   PubMedGoogle Scholar
• Simatupang T. A., Rado J. P., Boer P., Geyskes G. G., Ves J., Dorhout Mees E. J. Pharmacologic studies in Bartter's syndrome: Opposite effects of treatment with anti-kaliuretic and anti-prostag-landin drugs. Int. J. din. Pharmac. 1978; 16: 14
   Google Scholar
• Takayashu H., Aso Y., Nakauchi K., Kawabe K. A case of Bartter's syndrome with surgical treatment followed for 4 years. J. clin. Endocr. Metah 1971; 32: 842
   PubMedGoogle Scholar
• Trygstad C. W., Mangos J. A., Bloodworth J. M.B. A sibship with Banter's syndrome; failure of total adrenalectomy to correct the potassium wasting. Pediatrics 1969; 44: 234
   PubMedGoogle Scholar
• Vander A. C., Goelhood G. W. Inhibition of renin secretion by angiotensin II. Proc. Soc. expl. biol. Med. 1965; 120: 399
   PubMed Web of Science ®Google Scholar
• Verberckmoes R., van Damme B., Clement J., Amery A., Michielsen P. Bartter's syndrome with hyperplasia of renomedullary cells: Successful treatment with indomethacin. Kidney Int. 1976; 9: 302
   PubMed Web of Science ®Google Scholar
• Vinci J. M., Gill J. R., Jr., Bowden R. E., Pisano J. J., Izzo J. L., Jr., Radfar M., Taylor A. A., Zusman R. M., Bartter F. C., Keiser H. R. The kallikrein and its response to prostaglandin synthetase inhibition. J. clin. Invest. 1978; 61: 1671
   PubMed Web of Science ®Google Scholar
• Weber P. C., Scherer B., Larsson C. Increase of free arachidonic acid by fuoresmide in man as the cause of prostaglandin in renin release. Eur. J. Pharmac. 1977; 41: 329
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Dot K., Ogihara T., Ichihara K., Hata T., Kumahara M. Drugs affecting the renin-angiotensin-aldosterone system. Prog, biochem. Phamac. 1975; 12: 174
   Google Scholar